Association of Nonacute Opioid Use and Cardiovascular Diseases: A Scoping Review of the Literature
BACKGROUND In this scoping review, we identified and reviewed 23 original articles from the PubMed database that investigated the relationship between nonacute opioid use (NOU) and cardiovascular outcomes. METHODS AND RESULTS We defined NOU to include both long‐term opioid therapy and opioid use dis...
Saved in:
Published in | Journal of the American Heart Association Vol. 10; no. 13 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
John Wiley and Sons Inc
06.07.2021
Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | BACKGROUND
In this scoping review, we identified and reviewed 23 original articles from the PubMed database that investigated the relationship between nonacute opioid use (NOU) and cardiovascular outcomes.
METHODS AND RESULTS
We defined NOU to include both long‐term opioid therapy and opioid use disorder. We summarized the association between NOU and 5 classes of cardiovascular disease, including infective endocarditis, coronary heart disease (including myocardial infarction), congestive heart failure, cardiac arrythmia (including cardiac arrest), and stroke. The most commonly studied outcomes were coronary heart disease and infective endocarditis. There was generally consistent evidence of a positive association between community prevalence of injection drug use (with opioids being the most commonly injected type of drug) and community prevalence of infective endocarditis, and between (primarily medically indicated) NOU and myocardial infarction. There was less consensus about the relationship between NOU and congestive heart failure, cardiac arrhythmia, and stroke.
CONCLUSIONS
There is a dearth of high‐quality evidence on the relationship between NOU and cardiovascular disease. Innovative approaches to the assessment of opioid exposure over extended periods of time will be required to address this need. |
---|---|
Bibliography: | For Disclosures, see page 9. Supplementary Material for this article is available at https://www.ahajournals.org/doi/suppl/10.1161/JAHA.121.021260 |
ISSN: | 2047-9980 2047-9980 |
DOI: | 10.1161/JAHA.121.021260 |